This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 07/05/2023
Location: Silver Spring, MD
Subject: Update on Infant Formula
FDA Participant/Group: PETER BECKERMAN; ANDREW ZACHER;
Non FDA Participant/Group: Robert Ford (Abbott Laboratories);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 07/05/2023
Location: Washington, D.C.
Subject: Asia Pacific Economic Cooperation Issues
FDA Participant/Group: N/A
Non FDA Participant/Group: Chen Yongsheng (Embassy of the People's Republic of China);

Event Date: 07/06/2023
Location: Virtual
Subject: Strengthening Regulatory Systems
FDA Participant/Group: N/A
Non FDA Participant/Group: Carlos Santos-Burgoa (Milken Institute of Public Health);

Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/06/2023
Location: Virtual
Subject: 57th Advisory Committee on Blood, Tissue Safety, and Availability Meeting; Individual Donor Risk Assessment Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the 57th Advisory Committee on Blood, Tissue Safety, and Availability Meeting

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/06/2023
Location: Virtual
Subject: General Medical Device Updates
FDA Participant/Group: COURTNEY LIAS; WILLIAM MAISEL; KEISHA THOMAS;
Non FDA Participant/Group: Boris Shkolnik, Marcus Gesner, Pierre Boisier, Stefan Kaufmann, Todd Brill (Olympus Corporation);

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 07/07/2023
Location: Virtual
Subject: Reorganization of FDA Human Foods Program and Other Food Issues
FDA Participant/Group: N/A
Non FDA Participant/Group: Kathleen Donahue (Canadian Food Inspection Agency);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event